US 8933216
Immunosuppression compound and treatment method
granted A61PA61P3/00A61P37/00
Quick answer
US patent 8933216 (Immunosuppression compound and treatment method) held by Sarepta Therapeutics, Inc. expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P3/00, A61P37/00, A61P37/06